OpenAI Researcher Miles Wang in Talks to Launch $2B AI Drug-Discovery Startup

TechCrunch·medium signal

OpenAI researcher Miles Wang is reportedly in discussions to raise ~$200M at a $2B valuation for a new AI drug-discovery startup, with Lightspeed in talks to lead the round. It's another high-profile frontier-lab researcher spinning out into applied life sciences, mirroring the same-week Chai Discovery raise. Investor appetite for AI-for-bio remains intense even at pre-product valuations.